The position paper developed by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy provides recommendations for lipid management in rheumatoid arthritis.
Elevated levels of thyrotropin in patients with a history of chronic heart or renal failure may not always indicate thyroid disease.
Radiofrequency ablation and laser ablation are both safe and very effective for reducing the volume of thyroid nodules.
Researchers identified predictors of biochemical treatment response to antithyroid drugs, specifically methimazole, in patients with Graves disease.
The 8th edition of the American Joint Committee on Cancer staging system does not address disparities in outcomes in differentiated thyroid cancer.
Severe depression is associated with higher thyrotropin levels, according to results of a historical cohort study conducted at the University of Utah.
Vitamin D status was not linked to risk for thyroid immune-related adverse events in patients initiating immune checkpoint inhibitor therapy.
Treatment with liraglutide for type 2 diabetes was not associated with an increased risk for hospitalization for heart failure (HF) or cardiovascular death in patients with vs without a history of HF.
Patients with rheumatoid arthritis and a higher BMI were shown to have increased foot pain and foot-related activity limitations.
The combination of higher serum oxidized low-density lipoprotein (oxLDL) and LDL levels was found to be associated with an increased risk for recurrent stroke and poor functional outcomes in patients who have had minor stroke or are at high risk for transient ischemic attacks.
